Newly identified cells help explain why women experience autoimmune disease more often than men, a team reports in the Journal of Clinical Investigation. Continue reading
Experts are developing compounds that could allow the pain-relieving effects of ibuprofen to last longer, they report in Molecular Pharmaceutics. And the approach could also be used to deliver other drugs orally that currently can only be taken intravenously.
Metal-organic frameworks are compounds made of metal ions linked to organic ligands, for drug delivery. Active ingredients can be packed inside the metal organic frameworks. They are porous, and some dissolve in water so are good candidates for drug couriers.
The researchers loaded ibuprofen into metal organic frameworks. The compounds were found to reach the bloodstream (of mice) quickly and lasted for twice as long as ibuprofen salts, which are the active ingredient in liquid gel formulations.
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.
Modified red blood cells could reduce symptoms and onset of autoimmune diseases – early new findings
A new way of treating autoimmune diseases, by modifying the functions of red blood cells, is being developed by scientists, they report in the Proceedings of the National Academy of Sciences.
Singer Kelle Bryan was at the pinnacle of her pop star career when she was suddenly struck down with lupus. Her band, Eternal had sold over ten million records, notched up numerous awards, toured the world and even performed for Pope Jean Paul II. Continue reading
A previously unknown mechanism involved in the immune response may one day provide an alternative treatment for people with lupus, researchers report in Science Signaling. Continue reading